Technology | 2009.12.03
Genzyme reopens program for Pompe disease drug - Boston Globe
| Genzyme reopens program for Pompe disease drug Boston Globe Genzyme Corp., the Cambridge biotechnology company, said it will reopen enrollment to a program that provides treatment access to severely affected adults ... Genzyme's Lumizyme program back on track Genzyme to Reopen Enrollment in Alglucosidase Alfa Temporary Access Program |
For more information, please visit
http://news.google.com/news/url?fd=R&sa=[...]CNEf7kQM0FYsrf-oed9CkdcqJc2Kyg
